Table 4.
LV segment | 100% Dose | 50% Dose | 25% Dose | 12.5% Dose |
---|---|---|---|---|
| ||||
1 | 11.05 ± 2.32 | 10.94 ± 2.47 | 10.78 ± 2.52 | 10.72 ± 2.72 |
2 | 7.12 ± 2.40 | 7.29 ± 2.40 | 7.20 ± 2.38 | 6.91 ± 2.72 |
3 | 5.21 ± 2.35 | 5.38 ± 2.45 | 5.14 ± 2.53 | 4.87 ± 2.66 |
4 | 7.19 ± 2.49 | 7.19 ± 2.54 | 6.95 ± 2.61 | 6.33 ± 2.68 (P < 0.01) |
5 | 10.32 ± 2.41 | 10.36 ± 2.46 | 10.15 ± 2.75 | 9.25 ± 2.67 (P < 0.01) |
6 | 11.60 ± 2.16 | 11.59 ± 2.23 | 11.37 ± 2.52 | 10.22 ± 2.58 (P < 0.01) |
7 | 9.36 ± 2.32 | 9.19 ± 2.44 | 9.05 ± 2.47 | 8.98 ± 2.77 |
8 | 6.77 ± 2.60 | 6.80 ± 2.54 | 6.85 ± 2.60 | 6.75 ± 2.92 |
9 | 5.40 ± 2.48 | 5.45 ± 2.68 | 5.45 ± 2.64 | 5.12 ± 2.83 |
10 | 6.98 ± 2.45 | 6.98 ± 2.51 | 6.88 ± 2.51 | 6.57 ± 2.75 |
11 | 9.27 ± 2.26 | 9.38 ± 2.34 | 9.17 ± 2.43 | 8.89 ± 2.67 |
12 | 9.33 ± 2.10 | 9.38 ± 2.19 | 9.16 ± 2.51 | 9.12 ± 2.56 |
13 | 7.22 ± 2.46 | 7.18 ± 2.47 | 7.25 ± 2.57 | 7.36 ± 2.87 |
14 | 5.60 ± 3.02 | 5.42 ± 2.99 | 5.58 ± 3.06 | 5.48 ± 3.06 |
15 | 7.98 ± 2.97 | 7.94 ± 2.92 | 8.02 ± 3.12 | 7.74 ± 3.18 |
16 | 9.03 ± 2.70 | 9.06 ± 2.66 | 9.16 ± 2.80 | 9.23 ± 2.95 |
17 | 7.70 ± 3.06 | 7.74 ± 3.05 | 7.93 ± 3.34 | 7.78 ± 3.61 |
Statistical P values are given in italics
The results are given for 100% dose, 50%, 25%, and 12.5% of full dose. These results were obtained from 163 subjects. Post hoc ANOVA with correction for multiple comparisons indicates statistically significant differences between 12.5% dose and 100% dose in segments #4, #5, and #6, but not other segments